ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 90 filers reported holding ENZO BIOCHEM INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $43,000 | -33.8% | 7,880 | -0.6% | 0.01% | -50.0% |
| Q4 2017 | $65,000 | -21.7% | 7,925 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $83,000 | -4.6% | 7,925 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $87,000 | -53.7% | 7,925 | -64.7% | 0.02% | -53.3% |
| Q1 2017 | $188,000 | -87.9% | 22,420 | -90.0% | 0.04% | -88.4% |
| Q4 2016 | $1,554,000 | +35.2% | 223,931 | -0.8% | 0.39% | +34.8% |
| Q3 2016 | $1,149,000 | +114800.0% | 225,834 | +126064.2% | 0.29% | – |
| Q1 2015 | $1,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |